Aurobindo Pharma to acquire seven oncology products from US-based Spectrum Pharmaceuticals in a USD 300 mn deal: Regulatory filing.
Aurobindo Pharma to acquire seven oncology products from US-based Spectrum Pharmaceuticals in a USD 300 mn deal: Regulatory filing.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- aurobindo pharma
- price
- stock
- this is us
- oncology products
- spectrum pharmaceuticals
- us
Advertisement
ALSO READ
GLOBAL MARKETS-Asia stocks hesitant, dollar firms as US payrolls dent Fed rate cut wagers
China stocks fall on US rate concerns; economic data awaited
Indian stock indices hit fresh high; eyes now on inflation data, Q4 earnings
GLOBAL MARKETS-Asia stocks muted and dollar steady, US payrolls dent Fed rate cut wagers
Egypt's annual urban consumer price inflation decreased to 33.3% in March
Google News